2016
DOI: 10.3201/eid2207.151694
|View full text |Cite
|
Sign up to set email alerts
|

Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States

Abstract: Clinicians must consider patient medical history, timeline of symptoms, and hazards of alternative laboratory tests.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
66
0
3

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 133 publications
(69 citation statements)
references
References 36 publications
(76 reference statements)
0
66
0
3
Order By: Relevance
“…From the perspective of both clinical care and biomedical research, it is imperative to be able to identify disease cases accurately, and also to monitor the trajectory and response to intervention. The diagnostic workup for LD traditionally involves an assessment of the patient's risk, objective signs (such as an EM) and symptoms, supported by laboratory findings where appropriate [27]. In practice, this can be confounded by a number of factors, some of which are described below.…”
Section: Detecting and Characterizing Lyme Diseasementioning
confidence: 99%
“…From the perspective of both clinical care and biomedical research, it is imperative to be able to identify disease cases accurately, and also to monitor the trajectory and response to intervention. The diagnostic workup for LD traditionally involves an assessment of the patient's risk, objective signs (such as an EM) and symptoms, supported by laboratory findings where appropriate [27]. In practice, this can be confounded by a number of factors, some of which are described below.…”
Section: Detecting and Characterizing Lyme Diseasementioning
confidence: 99%
“…The standard of care for diagnosing disseminated Lyme disease is a two-tiered serologic approach that garners approximately 70–100% sensitivity and a specificity of approximately 95% [7]. The first tier involves either enzyme immunoassay (EIA) or an immunofluorescence assay (IFA) measuring the overall antibody response to either IgM or IgG [7].…”
Section: Discussionmentioning
confidence: 99%
“…The first tier involves either enzyme immunoassay (EIA) or an immunofluorescence assay (IFA) measuring the overall antibody response to either IgM or IgG [7]. If either of these results is equivocal or positive, an immunoblot should be used to detect antibodies against B. burgdorferi (Figure 3) [7].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations